Materno-Perinatal Hospital of the State of Mexico Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2020
NCT04341493
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Hugo Mendieta Zeron | Materno-Perinatal Hospital of the State of Mexico | Research Unit

Active Ingredients

Drugs in Phase 4 Trials (2)

hydroxychloroquine (plaquenil) (1 trial)

nitazoxanide (Alinia) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronavirus Infections (Phase 4)

Severe Acute Respiratory Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2